Like a blog, with focus on news in all of the categories listed here. Straight news, analysis, commentary.
Biogen Pays 22M To Resolve False Claims Act Charges For Paying Kickbacks
The Justice Department has announced that Biogen, Inc., has agreed to pay $22 million to resolve claims that it violated the False Claims Act by illegally using foundations as a conduit to pay the copays of Medicare patients taking Biogen’s multiple sclerosis drugs, Avonex and Tysabri. Biogen did not admit liability in reaching the agreement. […]











